全文获取类型
收费全文 | 137篇 |
免费 | 13篇 |
国内免费 | 3篇 |
专业分类
儿科学 | 1篇 |
妇产科学 | 5篇 |
基础医学 | 15篇 |
口腔科学 | 4篇 |
临床医学 | 11篇 |
内科学 | 56篇 |
皮肤病学 | 1篇 |
神经病学 | 8篇 |
外科学 | 9篇 |
综合类 | 1篇 |
预防医学 | 8篇 |
眼科学 | 1篇 |
药学 | 20篇 |
肿瘤学 | 13篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 7篇 |
2020年 | 3篇 |
2019年 | 9篇 |
2018年 | 9篇 |
2017年 | 7篇 |
2016年 | 9篇 |
2015年 | 14篇 |
2014年 | 9篇 |
2013年 | 13篇 |
2012年 | 13篇 |
2011年 | 12篇 |
2010年 | 7篇 |
2009年 | 3篇 |
2008年 | 5篇 |
2007年 | 5篇 |
2006年 | 3篇 |
2005年 | 4篇 |
2004年 | 2篇 |
2003年 | 1篇 |
2002年 | 4篇 |
2001年 | 1篇 |
1999年 | 2篇 |
1983年 | 1篇 |
1981年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有153条查询结果,搜索用时 15 毫秒
1.
2.
Shravankumar Kankala Niranjan Thota Fredrik Björkling Myles K. Taylor Ravinder Vadde Ramesh Balusu 《Drug development research》2019,80(2):188-199
Cancer is a major global health problem with large therapeutic challenges. Although substantial progress has been made in cancer therapy, there still remains a need to develop novel and effective treatment strategies to treat several relapsed and refractory cancers. Recently, there has been growing demand for considering organometallics as antineoplastic agents. This review is focused on a group of organometallics, silver N-heterocyclic carbene complexes (SCCs) and their anticancer efficacy in targeting multiple pathways in various in vitro cancer model systems. However, the precise molecular mechanism of SCCs anticancer properties remains unclear. Here, we discuss the SCCs chemistry, potential molecular targets, possible molecular mechanism of action, and their application in cancer therapies. 相似文献
3.
Asheebo Rojas Jianxiong Jiang Thota Ganesh Myung‐Soon Yang Nadia Lelutiu Paoula Gueorguieva Raymond Dingledine 《Epilepsia》2014,55(1):17-25
Epilepsy is one of the more prevalent neurologic disorders in the world, affecting approximately 50 million people of different ages and backgrounds. Epileptic seizures propagating through both lobes of the forebrain can have permanent debilitating effects on a patient's cognitive and somatosensory brain functions. Epilepsy, defined by the sporadic occurrence of spontaneous recurrent seizures (SRS), is often accompanied by inflammation of the brain. Pronounced increases in the expression of key inflammatory mediators (e.g., interleukin ‐1β [IL‐1β], tumor necrosis factor alpha [TNFα], cyclooxygenase‐2 [COX‐2], and C‐X‐C motif chemokine 10 [CXCL10]) after seizures may cause secondary damage in the brain and increase the likelihood of repetitive seizures. The COX‐2 enzyme is induced rapidly during seizures. The increased level of COX‐2 in specific areas of the epileptic brain can help to identify regions of seizure‐induced brain inflammation. A good deal of effort has been expended to determine whether COX‐2 inhibition might be neuroprotective and represent an adjunct therapeutic strategy along with antiepileptic drugs used to treat epilepsy. However, the effectiveness of COX‐2 inhibitors on epilepsy animal models appears to depend on the timing of administration. With all of the effort placed on making use of COX‐2 inhibitors as therapeutic agents for the treatment of epilepsy, inflammation, and neurodegenerative diseases there has yet to be a selective and potent COX‐2 inhibitor that has shown a clear therapeutic outcome with acceptable side effects. 相似文献
4.
Jiang J Ganesh T Du Y Quan Y Serrano G Qui M Speigel I Rojas A Lelutiu N Dingledine R 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(8):3149-3154
With interest waning in the use of cyclooxygenase-2 (COX-2) inhibitors for inflammatory disease, prostaglandin receptors provide alternative targets for the treatment of COX-2-mediated pathological conditions in both the periphery and the central nervous system. Activation of prostaglandin E2 receptor (PGE(2)) subtype EP2 promotes inflammation and is just beginning to be explored as a therapeutic target. To better understand physiological and pathological functions of the prostaglandin EP2 receptor, we developed a suite of small molecules with a 3-aryl-acrylamide scaffold as selective EP2 antagonists. The 12 most potent compounds displayed competitive antagonism of the human EP2 receptor with K(B) 2-20 nM in Schild regression analysis and 268- to 4,730-fold selectivity over the prostaglandin EP4 receptor. A brain-permeant compound completely suppressed the up-regulation of COX-2 mRNA in rat cultured microglia by EP2 activation and significantly reduced neuronal injury in hippocampus when administered in mice beginning 1 h after termination of pilocarpine-induced status epilepticus. The salutary actions of this novel group of antagonists raise the possibility that selective block of EP2 signaling via small molecules can be an innovative therapeutic strategy for inflammation-related brain injury. 相似文献
5.
6.
Nour Hamade Sreekar Vennelaganti Sravanthi Parasa Prashanth Vennalaganti Srinivas Gaddam Manon C.W. Spaander Sophie H. van Olphen Prashanthi N. Thota Kevin F. Kennedy Marco J. Bruno John J. Vargo Sharad Mathur Brooks D. Cash Richard Sampliner Neil Gupta Gary W. Falk Ajay Bansal Patrick E. Young Prateek Sharma 《Clinical gastroenterology and hepatology》2019,17(5):864-868
7.
8.
Hakimelahi GH Moosavi-Movahedi AA Sambaiah T Zhu JL Ethiraj KS Pasdar M Hakimelahi S 《European journal of medicinal chemistry》2002,37(3):207-217
Thiols are the most reactive nucleophilic reagents among the biological models investigated. The reactivity of butenolides 1a-c, 2-4, and 6-8 toward L-cysteine, a model biological nucleophile, was studied spectrophotometrically. The rates of the reactions were measured and correlated with antitumour activity of these molecules. N-Acetylcysteine addition product 5, resulting from the treatment of butenolide 4 with glutathione precursor, N-acetyl-L-cysteine, was isolated. Unlike purine-containing gamma-(Z)-ethylidene-2,3-dimethoxybutenolides 1a-c, 4, 6, and 7, adduct 5 and butenolides 10-12 did not exhibit inhibitory activity against murine leukemias (L1210 and P388), breast carcinoma (MCF7), and human T-lymphoblasts (Molt4/C8 and CEM/0) cell lines. As such, the biological activity of purine-containing butenolides can be attributed to their adenine moiety as a recognition site as well as their reactivity towards the cysteine residues of functional proteins forming covalent bond via reverse Michael type addition. Adenine-containing phosphonothioanhydride derivative 8 was also synthesised. Its reaction with N-acetyl-L-cysteine produced N,S-diacetylcysteine and thiophosphonate 9. Compound 9 did not exhibit anticancer activity; yet its precursor 8 displayed the most pronounced inhibition on all the examined malignant tumour cell lines. In the presence of L-cysteine, cytotoxicity of 4 and 8 was decreased, whereas glutathione addition more influenced on the cytotoxicity of 8. It was found that adenine-containing phosphonothioanhydride 8 functions as a significant irreversible inactivator of the Escherichia coli ribonucleoside diphosphate reductase. After treatment of MCF7 cells with compound 8, fluorescence microscopy demonstrated the presence of nucleus shrinkage or segmentation. This apoptotic morphology, however, was not pronounced in the presence of glutathione or dithiotheritol. 相似文献
9.
Karunakara Padhy Suri Bhaskara Rama Narsimham Thota Mohan Sankarji Maharaj Ponangi Venkata Satyanarayana 《Indian Journal of Thoracic and Cardiovascular Surgery》2008,24(2):154-155
Patients with massive haemoptysis with dense fibrosis, a standard pneumonectomy may lead to blood loss with life threatening
situation. Physiological Lung exclusion through mid sternotomy is an useful procedure. Four patients had undergone Physiological
Lung exclusion. Two patients for massive haemoptysis and two for redo lobectomy. All patients operated through mid sternotomy.
The last patient while hilar dissection lost significant blood volume and required cardiopulmonary bypass to complete the
procedure. This is an useful procedure when there is anticipation of difficulty in standard pneumonectomy and in sick patients. 相似文献
10.